Delivra Health Brands Inc.
DHBUF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7,304 | $5,823 | $6,373 | $5,282 |
| - Cash | $2,335 | $3,302 | $3,491 | $3,852 |
| + Debt | $1,569 | $2,113 | $2,226 | $2,151 |
| Enterprise Value | $6,538 | $4,634 | $5,108 | $3,581 |
| Revenue | $2,303 | $4,358 | $3,095 | $2,754 |
| % Growth | -47.2% | 40.8% | 12.4% | – |
| Gross Profit | $1,058 | $2,334 | $1,552 | $1,294 |
| % Margin | 46% | 53.6% | 50.1% | 47% |
| EBITDA | $7 | $649 | -$32 | -$388 |
| % Margin | 0.3% | 14.9% | -1% | -14.1% |
| Net Income | -$65 | $838 | -$422 | -$812 |
| % Margin | -2.8% | 19.2% | -13.6% | -29.5% |
| EPS Diluted | -0.002 | 0.012 | -0.014 | -0.026 |
| % Growth | -117.2% | 190.4% | 48.1% | – |
| Operating Cash Flow | -$199 | $414 | -$630 | -$333 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$199 | $414 | -$630 | -$333 |